Trial Profile
Intravenous Ferric Carboxymaltose (Ferinject) With or Without Erythropoietin for the Correction of Preoperative Anaemia in Patients Undergoing Orthopaedic Surgery
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Ferric carboxymaltose (Primary) ; Erythropoietin
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- 26 Jun 2014 New trial record